MJMakoto Jones

Makoto Jones

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Makoto Jones has a total of 62 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A flexible framework for visualizing and exploring patient misdiagnosis over time

    by Wathsala Widanagamaachchi, Kelly Peterson, Alec Chapman, David Classen, Makoto Jones


  • Open Access

    Variation and trends in transmission dynamics of Methicillin-resistant Staphylococcus aureus in veterans affairs hospitals and nursing homes

    by Karim Khader, Alun Thomas, Makoto Jones, Damon Toth, Vanessa Stevens, Matthew H. Samore


  • Open Access

    Protocol to disseminate a hospital-site controlled intervention using audit and feedback to implement guidelines concerning inappropriate treatment of asymptomatic bacteriuria

    by The Less is More Study Group, Barbara W. Trautner, Pooja Prasad, Larissa Grigoryan, Sylvia J. Hysong, Jennifer R. Kramer, Suja Rajan, Nancy J. Petersen, Tracey Rosen, Dimitri M. Drekonja, et al.

    Antimicrobial stewardship to combat the spread of antibiotic-resistant bacteria has become a national priority. This project focuses on reducing inappropriate use of antimicrobials for asymptomatic bacteriuria (ASB), a very common condition that leads to antimicrobial overuse in acute and long-term care. We previously conducted a successful intervention, entitled “Kicking Catheter Associated Urinary Tract Infection (CAUTI): the No Knee-Jerk Antibiotics Campaign,” to decrease guideline-discordant ordering of urine cultures and antibiotics for ASB. The current objective is to facilitate implementation of a scalable version of the Kicking CAUTI campaign across four geographically diverse Veterans Health Administration facilities while assessing what aspects of an antimicrobial stewardship intervention are essential to success and sustainability. This project uses an interrupted time series design with four control sites. The two main intervention tools are (1) an evidence-based algorithm that distills the guidelines into a streamlined clinical pathway and (2) case-based audit and feedback to train clinicians to use the algorithm. Our conceptual framework for the development and implementation of this intervention draws on May’s General Theory of Implementation. The intervention is directed at providers in acute and long-term care, and the goal is to reduce inappropriate screening for and treatment of ASB in all patients and residents, not just those with urinary catheters. The start-up for each facility consists of centrally-led phone calls with local site champions and baseline surveys. Case-based audit and feedback will begin at a given site after the start-up period and continue for 12 months, followed by a sustainability assessment. In addition to the clinical outcomes, we will explore the relationship between the dose of the intervention and clinical outcomes. This project moves from a proof-of-concept effectiveness study to implementation involving significantly more sites, and uses the General Theory of Implementation to embed the intervention into normal processes of care with usual care providers. Aspects of implementation that will be explored include dissemination, internal and external facilitation, and organizational partnerships. “Less is More” is the natural next step from our prior successful Kicking CAUTI intervention, and has the potential to improve patient care while advancing the science of implementation.


  • Open Access

    Exploring Visual Analytic Tools for Antimicrobial Stewardship Intervention across 8 Veterans Affairs Hospitals

    by Jesse Sutton, Christopher J Graber, Karl Madaras-Kelly, Makoto Jones, Peter Glassman, Emily Spivak, Matthew Goetz, The Veterans Affairs Antimicrobial Use Learning Collaborative

    Antimicrobial use (AU) measurement is a core element of antimicrobial stewardship (AS). Although National Healthcare Safety Network (NHSN) AU option and Standardized Antimicrobial Administration Ratios (SAAR) facilitate automated data collection and benchmarking, they are limited by inability to connect AU to indications or timing within a treatment course. We developed tools that analyze SAAR AU group data for pneumonia (PNA), urinary tract infection (UTI), and skin and soft-tissue infection (SSTI) at decision points within a treatment course: Choice (days 0–2), Change (3–4), and Completion (5–6) (CCC). The tool is being tested by AS teams at 8 VA hospitals. We report AU for PNA, UTI, and SSTI during 2016 in non-ICU patients to illustrate between facility variation within SAAR groups and patterns of change across CCC. There was substantial inter-site variation in the use of the SAAR groups across CCC for patients with PNA, UTI or SSTI (Figure). For all sites, the use of antibiotics with activity against MRSA or multi-drug resistant GNR (MDRO) decreased from Choice to Change and Completion. In contrast for Broad-Spectrum antibiotics used for Community-Acquired (CA) infections, use decreased over time for Sites, A, B, D, E and F, but not at sites C, G and H. The only SAAR group to show ≥5% increased use over CCC across all infections was Surgical Site Infection Prophylaxis (SSIP) antibiotics (sites F, G and H). Assessment by indication showed ≥5% increases for CA (PNA, site F; SSTI, sites B, C, D, E and G), SSIP (PNA, site F; UTI, sites F and H; SSTI, sites D, G and H), and MRSA (UTI, sites C and E); use of MDRO antibiotics consistently decreased. Our tool provides an automated method to analyze syndrome-specific AU at key decision points, which allowed AS teams to efficiently and reproducibly identify areas for intervention. The most notable inter-hospital variation was among the pattern of use CA and SSIP agents across CCC especially for SSTI as de-escalation to CA occurred at 5 sites and to SSIP at 3 sites. De-escalation to SSIP for PNA also occurred at one site. The contribution of treatment vs. prophylaxis indications for SSIP SAAR AU warrants further investigation given implications for AS intervention. All authors: No reported disclosures.

  • Identifying complexity in infectious diseases inpatient settings: An observation study

    by Don Roosan, Charlene Weir, Matthew Samore, Makoto Jones, Mumtahena Rahman, Gregory J. Stoddard, Guilherme Del Fiol


  • Open Access

    Description and validation of a spectrum score method to measure antimicrobial de-escalation in healthcare associated pneumonia from electronic medical records data

    by Karl Madaras-Kelly, Makoto Jones, Richard Remington, Christina Caplinger, Benedikt Huttner, Matthew Samore

    Comparison of antimicrobial de-escalation rates between healthcare settings is problematic. To objectively and electronically measure de-escalation a method based upon the spectrum of antimicrobial regimens administered (i.e., spectrum score) was developed. A Delphi process was used to develop applicable concepts. Spectrum scores were created for 27 antimicrobials based upon susceptibility for 19 organisms. National VA susceptibility data was used to estimate microbial spectrum. Susceptibility estimates were converted to ordinal scores, and values for organisms with multi-drug resistance potential were weighted more heavily. Organism scores were summed to create antibiotic-specific spectrum scores and extended mathematically to score multi-antimicrobial regimens. Vignettes were created from antimicrobial regimens administered to 300 patients hospitalized with pneumonia. Daily spectrum scores were calculated for each case. Hospitalization day 4 scores were subtracted from day 2 scores (i.e., spectrum score ∆). A positive spectrum score ∆ defined de-escalation. Experts ranked each pneumonia case on a 7-point Likert scale (Likert >4 indicated de-escalation). Spectrum score ∆s were compared to expert review. Findings were used to identify score deficiencies. Next, 40 pairs of cases were modified to include antimicrobial administration routes. Each pair contained almost similar regimens; however, one contained oral (PO) the other only intravenous (IV) antimicrobials on day 4 of therapy. Experts reviewed cases as described. Spectrum score ∆ credits to account for PO conversion were derived from the mean paired differences in Likert Score. De-escalation status was evaluated in 100 vignettes containing antimicrobial route by different experts and compared to the modified method. Initial sensitivity and specificity of the spectrum score ∆ to detect expert classified de-escalation events was 86.3 and 96.0%, respectively. In paired cases, the mean (± SD) Likert score was 5.0 (1.5) and 4.6 (1.5) for PO and IV (P = 0.002), respectively. To improve de-escalation event detection, two credits were added to spectrum score ∆s based upon the percentage of antimicrobials administered PO on day 4. The final method, exhibited sensitivity and specificity to detect expert classified de-escalation events of 96.2 and 93.6%, respectively. The final spectrum score method exhibited excellent agreement with expert judgments of de-escalation events in pneumonia.


    • 1 January 2015
      • Vol. 216, 1035

    Extraction of Vital Signs from Clinical Notes.

    by Olga V Patterson, Makoto Jones, Yiwen Yao, Benjamin Viernes, Patrick Alba, Theodore J Iwashyna, Scott L Duvall

    Assessment of vital signs is an essential part of surveillance of critically ill patients to detect condition changes and clinical deterioration. While most modern electronic medical records allow for vitals to be recorded in a structured format, the frequency and quality of what is electronically stored may differ from how often these measures are actually recorded. We created a tool that extracts blood pressure, heart rate, temperature, respiratory rate, blood oxygen saturation, and pain level from nursing and other clinical notes recorded in the course of inpatient care to supplement structured vital sign data.


  • Open Access

    Drugs of Last Resort? The Use of Polymyxins and Tigecycline at US Veterans Affairs Medical Centers, 2005–2010

    by Benedikt Huttner, Makoto Jones, Michael A. Rubin, Melinda M. Neuhauser, Adi Gundlapalli, Matthew Samore

    Multidrug-resistant (MDR) and carbapenem-resistant (CR) Gram-negative pathogens are becoming increasingly prevalent around the globe. Polymyxins and tigecycline are among the few antibiotics available to treat infections with these bacteria but little is known about the frequency of their use. We therefore aimed to estimate the parenteral use of these two drugs in Veterans Affairs medical centers (VAMCs) and to describe the pathogens associated with their administration. For this purpose we retrospectively analyzed barcode medication administration data of parenteral administrations of polymyxins and tigecycline in 127 acute-care VAMCs between October 2005 and September 2010. Overall, polymyxin and tigecycline use were relatively low at 0.8 days of therapy (DOT)/1000 patient days (PD) and 1.6 DOT/1000PD, respectively. Use varied widely across facilities, but increased overall during the study period. Eight facilities accounted for three-quarters of all polymyxin use. The same statistic for tigecycline use was twenty-six VAMCs. There were 1,081 MDR or CR isolates during 747 hospitalizations associated with polymyxin use (1.4/hospitalization). For tigecycline these number were slightly lower: 671 MDR or CR isolates during 500 hospitalizations (1.3/hospitalization) (p = 0.06). An ecological correlation between the two antibiotics and combined CR and MDR Gram-negative isolates per 1000PD during the study period was also observed (Pearson’s correlation coefficient r = 0.55 polymyxin, r = 0.19 tigecycline). In summary, while polymyxin and tigecycline use is low in most VAMCs, there has been an increase over the study period. Polymyxin use in particular is associated with the presence of MDR Gram-negative pathogens and may be useful as a surveillance measure in the future.


  • Open Access

    Identification of methicillin-resistant Staphylococcus aureus within the Nation’s Veterans Affairs Medical Centers using natural language processing

    by Makoto Jones, Scott L DuVall, Joshua Spuhl, Matthew H Samore, Christopher Nielson, Michael Rubin

    Accurate information is needed to direct healthcare systems’ efforts to control methicillin-resistant Staphylococcus aureus (MRSA). Assembling complete and correct microbiology data is vital to understanding and addressing the multiple drug-resistant organisms in our hospitals.